Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression.
We analyzed genomic data from the prostate cancer of African- and European American men to identify differences contributing to racial disparity of outcome. We also performed FISH-based studies of Chromodomain helicase DNA-binding protein 1 (CHD1) loss on …